Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Aditya Bagrodia

Urology
Regents Of The University Of California
200 W Arbor Dr, 
San Diego, CA 
Offers Telehealth
17 Years of Experience
Advanced in WT1-Related Wilms Tumor Syndromes
Regents Of The University Of California
200 W Arbor Dr, 
San Diego, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Aditya Bagrodia is an Urologist in San Diego, California. Dr. Bagrodia has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Urothelial Cancer, Orchiectomy, and Nephrectomy.

His clinical research consists of co-authoring 254 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
2009
Specialties
Urology
Licenses
Urology in CA
Hospital Affiliations
Uc San Diego Health Hillcrest - Hillcrest Med Ctr
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

REGENTS OF THE UNIVERSITY OF CALIFORNIA
200 W Arbor Dr, San Diego, CA 92103

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer
Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Drug
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2025
Intervention Type: Procedure, Other
Study Phase: Not Applicable
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Procedure, Other
View 2 Less Clinical Trials

254 Total Publications

Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT).
Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT).
Journal: JCO oncology practice
Published: September 30, 2025
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Carol E. Salem
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Carol E. Salem
Urology

On Call Specialists Medical Group Of San Diego Inc

4077 5th Ave, 
San Diego, CA 
 (0.4 miles away)
619-359-6600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Carol Salem is an Urologist in San Diego, California. Dr. Salem is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Familial Prostate Cancer, Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Reconstructive Urology Surgery, and Hernia Surgery.

Christopher J. Kane
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christopher J. Kane
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Christopher J. Kane
Urology

Regents Of The University Of California

200 W Arbor Dr, 
San Diego, CA 
 (0.1 miles away)
858-249-6753
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Kane is an Urologist in San Diego, California. Dr. Kane is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ramdev Konijeti
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Ramdev Konijeti
Urology

Scripps Health

10666 N Torrey Pines Rd, 
La Jolla, CA 
 (10.8 miles away)
858-554-9100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ramdev Konijeti is an Urologist in La Jolla, California. Dr. Konijeti is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, Reconstructive Urology Surgery, and Nephrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bagrodia's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 16 Advanced Conditions
View All 40 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile